Supplementary Figure S1 from RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations
Key Points
Key points are not available for this paper at this time.
Abstract
Supplementary Figure 1. RLY-4008 is an irreversible inhibitor of FGFR2.
AI에게 질문
Like
Bookmark
Share
AI에게 질문
Like
Bookmark
Share
Supplementary Figure S1 from RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations | Synapse